ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
BN
Brazilian National Cancer Institute (INCA) at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Brazilian National Cancer Institute (INCA) takes part in 7 sessions at ESMO 2026 in Madrid. Its work spans breast, ovarian and endometrial cancers, as well as cancer care and policy. It assesses evidence on breast cancer treatments and whether progression-free survival can stand in for overall survival in ovarian cancer trials.
| Organization | ESMO 2026 Attendance |
|---|---|
BN Brazilian National Cancer Institute (INCA) Rio de Janeiro, Brazil | |
Federal cancer institute of Brazil's health ministry in Rio de Janeiro, running cancer hospitals, research and national cancer control policy. | Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Chair Sat Oct 24 14:45–16:15 Abstract Sat Oct 24 14:55–15:05 Poster Sun Oct 25 12:00–12:45 Synthetic harmonization of non-exchangeable leiomyosarcoma cohorts creates comparable cross-trial anchors Sarcoma, CNS, head & neck and rare cancers |
Find decision makers at Brazilian National Cancer Institute (INCA)
Tell us what you sell and we’ll find the people at Brazilian National Cancer Institute (INCA) most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction